Drainage work keeps Azad away from his home
TWO MONTHS ON, UNION MINISTER COULDN’T VISIT HIS PRIVATE RESIDENCE
M HYDERI
Srinagar, Nov 19: How inconvenient it must have been for thousands of south City residents to bear with the situation arising out of slow work on the mega drainage project, which has missed deadlines by over three years? Well, ask Union Minister for Health, Ghulam Nabi Azad, who hasn’t visited More
Harwan seeks bridge construction
We The srinagarites
PEOPLE of Chandpora Harwan, Dara, Dharbagh, Fakir Gujjari, Danihama and adjoining areas are up in arms against the authorities for failing to construct bridge on a stream near Chandpora. The government had sanctioned the bridge construction earlier and the work was started. But after few days MoreNew Colony Makeen Bagh seeks transformer
GK NEWS NETWORK
Srinagar, Nov 19: The residents of New Colony Makeen Bagh, Naag Bal in Elahi Bagh area have appealed the Power Development Department to install a separate transformer in the area. A delegation of the residents said they were being fed by a transformer feeding some other locality. “This has More- Kashmir
7 medical shops sealed
‘Don’t target licensed pharma professionals’
IMRAN MUZAFFAR PARRAY
Srinagar, Nov 19: Authorities on Saturday sealed seven medical shops outside SMHS hospital here on the charges of violating the provisions of license under the Drug & Cosmetic Act. Officials More
- Srinagar City
Drainage work keeps Azad away from his home
TWO MONTHS ON, UNION MINISTER COULDN’T VISIT HIS PRIVATE RESIDENCE
M HYDERI
Srinagar, Nov 19: How inconvenient it must have been for thousands of south City residents to bear with the situation arising out of slow work on the mega drainage project, which has missed deadlines by More
- Jammu
17 hurt in Doda accident
FAIZ ALI TRAMBOO
Doda, Nov 19: In yet another mishap within two days, atleast 17 persons were wounded in a head on collision between a bus and a tanker near Kanderi Nallah at Assar area of Doda district. Eyewitnesses More
- News
Cancer drug Avastin loses US approval
Washington, Nov 19: US drug regulators have rescinded approval of a breast cancer drug, saying it is not effective enough to justify the risks of taking it. The drug, Avastin, was approved for US More


